Value of Oesophagal Videocapsul and Oeso-gastro-duodenal Fiber Endoscopy for the Screening of Oesophagal Varix for Cirrhotic Patients

NCT ID: NCT00941421

Last Updated: 2013-06-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

310 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-09-30

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the equivalence or not of diagnosis ability of oesophagal videocapsul versus oeso-gastro-duodenal fiber endoscopy in the screening of oesophagal varix.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cirrhotic Patient With Suspicion of Portal Hypertension and in a OV Screening Context

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

videocapsul and OGDFE

Each patient have a Fiberoptic endoscopy by videocapsul, followed by one traditional oeso-gastro-duodenal fiberoptic endoscopy

Group Type OTHER

oesophagal videocapsule and oeso-gastro-duodenal fiberoptic endoscopy

Intervention Type DEVICE

each patient receive one OVC and one OGDFE the same day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

oesophagal videocapsule and oeso-gastro-duodenal fiberoptic endoscopy

each patient receive one OVC and one OGDFE the same day

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18\< age\< 80
* Diagnosis of a cirrhosis
* suspicion of portal hypertension without known diagnosis of a cirrhosis
* Able to give an inform consent

Exclusion Criteria

Related to pouplation

* case history of cancer or oesophagal surgery
* case history of an ORL cancer
* case history of evolutive cancer

Related to pathology

* Previous fiberoptic endoscopy with OV diagnosis
* Less than 6 month since last fiberoptic endoscopy

Related to tested device

* clinical suspicion of oesophagal stenosis for a patient presenting a dysphagia to solids
* Zenker diverticuls attested
* clinical suspicion of small intestinal stenosis
* patient with pace-maker or any other inter device
* pregnant women
* deglutition troubles withfalse passage and/or conscience troubles
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Angers

Angers, , France

Site Status

CH Avicenne

Bobigny, , France

Site Status

CH Beaujon

Clichy, , France

Site Status

CH Saint Philibert

Lomme, , France

Site Status

CH Lyon - Herriot

Lyon, , France

Site Status

Hôpital la conception

Marseille, , France

Site Status

CHU Nantes

Nantes, , France

Site Status

CH Cochin

Paris, , France

Site Status

CHU Bordeaux

Pessac, , France

Site Status

CHU Strasbourg

Strasbourg, , France

Site Status

CHU Toulouse - Purpan

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Cales P, Sacher-Huvelin S, Valla D, Bureau C, Olivier A, Oberti F, Boursier J, Galmiche JP; multicenter group VO-VCO. Large oesophageal varice screening by a sequential algorithm using a cirrhosis blood test and optionally capsule endoscopy. Liver Int. 2018 Jan;38(1):84-93. doi: 10.1111/liv.13497. Epub 2017 Jul 7.

Reference Type DERIVED
PMID: 28622450 (View on PubMed)

Sacher-Huvelin S, Cales P, Bureau C, Valla D, Vinel JP, Duburque C, Attar A, Archambeaud I, Benamouzig R, Gaudric M, Luet D, Couzigou P, Planche L, Galmiche JP, Coron E. Screening of esophageal varices by esophageal capsule endoscopy: results of a French multicenter prospective study. Endoscopy. 2015 Jun;47(6):486-92. doi: 10.1055/s-0034-1391393. Epub 2015 Mar 2.

Reference Type DERIVED
PMID: 25730284 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BRD 09/5-G

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Confocal Laser Endomicroscopy
NCT00561938 COMPLETED NA
Endoscopy Quality Study
NCT03351790 UNKNOWN
a/LCI-OCT Pilot in Esophagus
NCT04392167 COMPLETED NA